WolverHeme Happy Hour
En podcast af Bernard Marini, Anthony Perissinotti, et al.
31 Episoder
-
Episode 10: ASH Recap Part 2 - Papa Heme + WolverHeme
Udgivet: 21.12.2022 -
Episode 9: ASH Recap Part 1 - Dauno-Double Trouble
Udgivet: 14.12.2022 -
Episode 8: Pulling the Goalie on FLT3 Inhibitor Use in AML - A Discussion with Dr. Dale Bixby
Udgivet: 23.11.2022 -
Episode (3+)7: Straight Outta Roswell - OG AML Data
Udgivet: 7.10.2022 -
Episode 6: Dr. StrangeDrug or: How I Learned to Stop Worrying and Love the Asparaginase
Udgivet: 21.7.2022 -
Episode 5: IDH Inhibitors in AML: not so AGILE
Udgivet: 3.6.2022 -
Episode 4: All Aboard the Oncology StewardSHIP
Udgivet: 27.5.2022 -
Episode 3.2: Ranting About Rituximab in Acute Lymphoblastic Leukemia
Udgivet: 22.4.2022 -
Episode 3.1: History of Acute Lymphoblastic Leukemia Treatment and Building the BFM Backbone
Udgivet: 22.4.2022 -
Episode 2: We Don't Talk About Rylaze
Udgivet: 18.3.2022 -
Episode 1: Surrogate Endpoints in AML
Udgivet: 11.3.2022
Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.